Busan, South Korea

Jae Seon Kang

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Korean Drug Co., Ltd.. Active years: 2020-2021.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2020-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jae Seon Kang: Innovator in Ginseng Saponin Research

Introduction

Jae Seon Kang is a notable inventor based in Busan, South Korea. He has made significant contributions to the field of ginseng saponin research, holding 2 patents that focus on the health benefits of ginseng compounds. His work has implications for cell longevity and blood health.

Latest Patents

Kang's latest patents revolve around a composition containing saponins as an active ingredient. These patents disclose the uses of ginseng saponin, which contains at least 90% of compounds K, Rd, F2, and Rg3. The main effects of these compounds include extending the lifespan of cells, promoting cell differentiation, increasing the number of red blood cells, and reducing triglycerides. The process involves extracting, heat-treating, and enzyme-converting ginseng saponin to prepare active saponins Rd, F2, and Rg3, including compound K.

Career Highlights

Jae Seon Kang is currently associated with Korean Drug Co., Ltd., where he continues to innovate in the field of medicinal compounds. His research has garnered attention for its potential health benefits and applications in the pharmaceutical industry.

Collaborations

Kang has worked alongside notable colleagues such as Sin-Ja Bae and Seo Hyun Lee, contributing to a collaborative environment that fosters innovation and research excellence.

Conclusion

Jae Seon Kang's work in ginseng saponin research highlights his commitment to advancing health through innovative solutions. His patents reflect a deep understanding of the medicinal properties of ginseng, paving the way for future developments in this field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…